Herriot Tabuteau
2018
In 2018, Herriot Tabuteau earned a total compensation of $1.1M as Chief Executive Officer and Chairman of the Board at Axsome Therapeutics, a 6% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $261,000 |
|---|---|
| Option Awards | $361,425 |
| Salary | $435,000 |
| Total | $1,057,425 |
Tabuteau received $435K in salary, accounting for 41% of the total pay in 2018.
Tabuteau also received $261K in non-equity incentive plan and $361.4K in option awards.
Rankings
In 2018, Herriot Tabuteau's compensation ranked 8,950th out of 14,244 executives tracked by ExecPay. In other words, Tabuteau earned more than 37.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,950 out of 14,244 | 37th |
Division Manufacturing | 3,560 out of 5,759 | 38th |
Major group Chemicals And Allied Products | 1,343 out of 2,122 | 37th |
Industry group Drugs | 1,126 out of 1,811 | 38th |
Industry Pharmaceutical Preparations | 876 out of 1,385 | 37th |
Source: SEC filing on April 21, 2020.
Tabuteau's colleagues
We found two more compensation records of executives who worked with Herriot Tabuteau at Axsome Therapeutics in 2018.